Saxagliptin
Inquiry
| Post Date: | Feb 04,2015 |
| Expiry Date: | Feb 04,2016 |
| Detailed Description: |
Cas No. :361442-04-8
Product name: Saxagliptin
CAS: 361442-04-8 Molecular formula: C18H25N3O2 Molecular weight: 315.414 Description: Saxagliptin (rINN), previously identified as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug. In June 2008, it was announced that Onglyza would be the trade name under which saxagliptin will be marketed. While used for type 2 diabetes the evidence does not show a change in hard end points such as the risk of heart attacks or strokes. |
| CAS Registry Number: | 361442-04-8 |
| Synonyms: | ;BMS 477118;Onglyza;(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;(1S,3S,5S)-2-[2(S)-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; |
| Molecular Formula: | C18H25N3O2 |
| Molecular Weight: | 315.41 |
| Molecular Structure: | 
|
| Company: | AUSMAUCO BIOTECH CO., LIMITED [ China ] |
| Contact: | john |
| Tel: | +8618060810639 |
| Fax: | |
| Email: | plantsale@aus-bio.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
